Milestone study on pomegranate anti-aging mechanism reported by Amazentis SA and EPFL

(Burns McClellan) Amazentis SA, an innovative life sciences company applying scientific breakthroughs in nutrition to manage health conditions linked to aging, announced today a collaborative publication in Nature Medicine with the Ecole Polytechnique Federale Lausanne, demonstrating that the Company's lead product candidate, urolithin A, improves mitochondrial and muscle function, resulting in enhanced muscle strength and endurance during aging. Amazentis is presently evaluating urolithin A in a first human clinical trial with results expected in 2017.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news